Pfizer reported growth of its quarterly revenue and profit by 45%. Sales of the vaccine against COVID-19 yielded $3.5 billion, which was 59% than forecast. However, after the report was published, the shares grew by 0.3% only.
All posts
Pandemic, quarantine, vaccines, the growth of the IT sector, antitrust litigation of technology corporations, the explosive success of Tesla, and, of course, Brexit - these are our most significant events of the year.
The vaccine developed by Pfizer and BioNTech is officially the first FDA-approved vaccine against COVID 19. In this article, we will define the arguments and try to figure out whether it will be possible to make money on investments in these companies.
What does the appearance of the new strain mean?
Now those investors who missed the growth of stock prices in summer have to look for something to make money on. The time has come to pay attention to pharmaceutical companies again.
COVID-19. Unofficially, we have a vaccine. Officially, we might have it in May.